{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:12:09Z","timestamp":1779207129987,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04176-6","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T14:02:37Z","timestamp":1766930557000},"page":"2246-2258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical evaluation of EGFR protein expression and microvascular density reveals an angiogenic signature in Tunisian patients with metastatic colorectal cancer"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1676-5142","authenticated-orcid":false,"given":"Amira Jaballah","family":"Gabteni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Ben Ayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Yaiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Ben Jemii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorra","family":"Wider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Ardhaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emna","family":"Fehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afifa","family":"Maaloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essia","family":"Habbechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emna","family":"Ennaifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Tounsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"issue":"6","key":"4176_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4176_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2023;34(1):10\u201332.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"4176_CR3","unstructured":"Masson E, EM-Consulte. Epid\u00e9miologie du cancer colorectal chez les sujets \u00e2g\u00e9s en Tunisie, 1990\u20132019. 2025. https:\/\/www.em-consulte.com\/article\/1532876\/epidemiologie-du-cancer-colorectal-chez-les-sujets"},{"issue":"1","key":"4176_CR4","first-page":"158","volume":"99","author":"S Rejaibi","year":"2021","unstructured":"Rejaibi S, Mahfoudh Mchirgui R, Ben Mansour N, Barbouch F, Kaddour N, Mrabet A, et al. Colorectal cancer mass screening, Tunisia 2019. Evaluation of a pilot program in the Tunis region (Tunisia, 2019). Tunis Med. 2021;99(1):158\u201367.","journal-title":"Tunis Med"},{"issue":"4","key":"4176_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2217\/fon.14.279","volume":"11","author":"L Foltran","year":"2015","unstructured":"Foltran L, De Maglio G, Pella N, Ermacora P, Aprile G, Masiero E, et al. Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncol Lond Engl. 2015;11(4):629\u201340.","journal-title":"Future Oncol Lond Engl"},{"issue":"1","key":"4176_CR6","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1186\/s12885-023-11600-z","volume":"23","author":"X Lu","year":"2023","unstructured":"Lu X, Li Y, Li Y, Zhang X, Shi J, Feng H, et al. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer. 2023;23(1):1117.","journal-title":"BMC Cancer"},{"issue":"5","key":"4176_CR7","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.3390\/ijms26051988","volume":"26","author":"J Haynes","year":"2025","unstructured":"Haynes J, Manogaran P. Mechanisms and strategies to overcome drug resistance in colorectal cancer. Int J Mol Sci. 2025;26(5):1988.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4176_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm0603-653","volume":"9","author":"P Carmeliet","year":"2003","unstructured":"Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9(6):653\u201360.","journal-title":"Nat Med"},{"issue":"3","key":"4176_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/cas.16063","volume":"115","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zhang X, Bai X, Xi X, Liu W, Zhong W. Anti-angiogenesis in colorectal cancer therapy. Cancer Sci. 2024;115(3):734\u201351. https:\/\/doi.org\/10.1111\/cas.16063.","journal-title":"Cancer Sci"},{"issue":"10","key":"4176_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/modpathol.3800417","volume":"18","author":"J Shia","year":"2005","unstructured":"Shia J, Klimstra DS, Li AR, Qin J, Saltz L, Teruya-Feldstein J, et al. Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Mod Pathol. 2005;18(10):1350\u20136.","journal-title":"Mod Pathol"},{"key":"4176_CR11","doi-asserted-by":"crossref","unstructured":"Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer Oxf Engl 1990. 2002;38(12):1564\u201379.","DOI":"10.1016\/S0959-8049(02)00094-1"},{"issue":"9","key":"4176_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2005.08.037","volume":"23","author":"KY Chung","year":"2005","unstructured":"Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, et al. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(9):1803\u201310.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"13","key":"4176_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12967-015-0531-z","volume":"7","author":"RA Hutchinson","year":"2015","unstructured":"Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW. Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer. J Transl Med. 2015;7(13):217.","journal-title":"J Transl Med"},{"issue":"17","key":"4176_CR14","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/S0014-4827(08)00404-7","volume":"314","author":"A Sorkin","year":"2008","unstructured":"Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res. 2008;314(17):3093\u2013106.","journal-title":"Exp Cell Res"},{"issue":"1","key":"4176_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2011.03.012","volume":"131","author":"AK Larsen","year":"2011","unstructured":"Larsen AK, Ouaret D, El Ouadrani K, Petitprez A. Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther. 2011;131(1):80\u201390.","journal-title":"Pharmacol Ther"},{"key":"4176_CR16","unstructured":"Structure and dynamics of the EGFR\/HER2 heterodimer | Cell Discovery. 2025. https:\/\/www.nature.com\/articles\/s41421-023-00523-5"},{"issue":"3","key":"4176_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/cancers12030614","volume":"12","author":"A Uhlyarik","year":"2020","unstructured":"Uhlyarik A, Piurko V, Papai Z, Raso E, Lahm E, Kiss E, et al. EGFR protein expression in KRAS wild-type metastatic colorectal cancer is another negative predictive factor of the cetuximab therapy. Cancers. 2020;12(3):614.","journal-title":"Cancers"},{"issue":"1","key":"4176_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/00006676-200407000-00061","volume":"29","author":"S Ueda","year":"2004","unstructured":"Ueda S, Ogata S, Tsuda H, Kawarabayashi N, Kimura M, Sugiura Y, et al. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma. Pancreas. 2004;29(1):e1\u20138.","journal-title":"Pancreas"},{"issue":"6","key":"4176_CR19","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1007\/s13277-015-4543-3","volume":"37","author":"S Bonin","year":"2016","unstructured":"Bonin S, Donada M, Bussolati G, Nardon E, Annaratone L, Pichler M, et al. A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients. Tumor Biol. 2016;37(6):7295\u2013303. https:\/\/doi.org\/10.1007\/s13277-015-4543-3.","journal-title":"Tumor Biol"},{"issue":"6","key":"4176_CR20","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2014.01.051","volume":"156","author":"F Supek","year":"2014","unstructured":"Supek F, Mi\u00f1ana B, Valc\u00e1rcel J, Gabald\u00f3n T, Lehner B. Synonymous mutations frequently act as driver mutations in human cancers. Cell. 2014;156(6):1324\u201335.","journal-title":"Cell"},{"issue":"6","key":"4176_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/bies.20592","volume":"29","author":"JL Parmley","year":"2007","unstructured":"Parmley JL, Hurst LD. How do synonymous mutations affect fitness? BioEssays News Rev Mol Cell Dev Biol. 2007;29(6):515\u20139.","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"key":"4176_CR22","doi-asserted-by":"publisher","first-page":"1394997","DOI":"10.3389\/fphar.2024.1394997","volume":"15","author":"M Tawengi","year":"2024","unstructured":"Tawengi M, Al-Dali Y, Tawengi A, Benter IF, Akhtar S. Targeting the epidermal growth factor receptor (EGFR\/ErbB) for the potential treatment of renal pathologies. Front Pharmacol. 2024;15:1394997.","journal-title":"Front Pharmacol"},{"key":"4176_CR23","doi-asserted-by":"publisher","first-page":"816801","DOI":"10.3389\/fonc.2022.816801","volume":"12","author":"WJ Wu","year":"2022","unstructured":"Wu WJ, Yang SH, Chung HP, Yen CT, Chen YT, Chang WC, et al. EGFR Q787Q polymorphism is a germline variant and a prognostic factor for lung cancer treated with TKIs. Front Oncol. 2022;12:816801.","journal-title":"Front Oncol"},{"issue":"6","key":"4176_CR24","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/ijms18061295","volume":"18","author":"S Keller","year":"2017","unstructured":"Keller S, Schmidt MHH. EGFR and EGFRvIII promote angiogenesis and cell invasion in glioblastoma: combination therapies for an effective treatment. Int J Mol Sci. 2017;18(6):1295.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4176_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neo.2015.08.002","volume":"17","author":"P Minder","year":"2015","unstructured":"Minder P, Zajac E, Quigley JP, Deryugina EI. EGFR regulates the development and microarchitecture of intratumoral angiogenic vasculature capable of sustaining cancer cell intravasation. Neoplasia. 2015;17(8):634\u201349.","journal-title":"Neoplasia"},{"issue":"1","key":"4176_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7","volume":"184","author":"JS de Jong","year":"1998","unstructured":"de Jong JS, van Diest PJ, van der Valk P, Baak JP. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: correlations with proliferation and angiogenesis. J Pathol. 1998;184(1):53\u20137.","journal-title":"J Pathol"},{"issue":"3","key":"4176_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.bjc.6603875","volume":"97","author":"Y Nieto","year":"2007","unstructured":"Nieto Y, Woods J, Nawaz F, Baron A, Jones RB, Shpall EJ, et al. Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy. Br J Cancer. 2007;97(3):391\u20137.","journal-title":"Br J Cancer"},{"issue":"3","key":"4176_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.rvsc.2013.09.003","volume":"95","author":"MI Carvalho","year":"2013","unstructured":"Carvalho MI, Guimar\u00e3es MJ, Pires I, Prada J, Silva-Carvalho R, Lopes C, et al. EGFR and microvessel density in canine malignant mammary tumours. Res Vet Sci. 2013;95(3):1094\u20139.","journal-title":"Res Vet Sci"},{"issue":"2","key":"4176_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pharmthera.2013.09.003","volume":"141","author":"G Mountzios","year":"2014","unstructured":"Mountzios G, Pentheroudakis G, Carmeliet P. Bevacizumab and micrometastases: revisiting the preclinical and clinical rollercoaster. Pharmacol Ther. 2014;141(2):117\u201324.","journal-title":"Pharmacol Ther"},{"key":"4176_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fcell.2017.00101","volume":"5","author":"V Comunanza","year":"2017","unstructured":"Comunanza V, Bussolino F. Therapy for cancer: strategy of combining anti-angiogenic and target therapies. Front Cell Dev Biol. 2017;5:101.","journal-title":"Front Cell Dev Biol."},{"issue":"5","key":"4176_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/cancers13051031","volume":"13","author":"TF Hansen","year":"2021","unstructured":"Hansen TF, Qvortrup C, Pfeiffer P. Angiogenesis inhibitors for colorectal cancer. A review of the clinical data. Cancers. 2021;13(5):1031.","journal-title":"Cancers"},{"issue":"29","key":"4176_CR32","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1200\/JCO.2007.12.0949","volume":"25","author":"LB Saltz","year":"2007","unstructured":"Saltz LB, Lenz HJ, Kindler HL, Hochster HS, Wadler S, Hoff PM, et al. Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(29):4557\u201361.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"4176_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1056\/NEJMoa0808268","volume":"360","author":"J Tol","year":"2009","unstructured":"Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJM, Schrama JG, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med. 2009;360(6):563\u201372.","journal-title":"N Engl J Med"},{"issue":"7","key":"4176_CR34","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1158\/1078-0432.CCR-09-2017","volume":"16","author":"JR Hecht","year":"2010","unstructured":"Hecht JR, Mitchell E, Neubauer MA, Burris HA, Swanson P, Lopez T, et al. Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2010;16(7):2205\u201313.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"4","key":"4176_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","volume":"8","author":"O Casanovas","year":"2005","unstructured":"Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005;8(4):299\u2013309.","journal-title":"Cancer Cell"},{"issue":"4","key":"4176_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6(4):273\u201386.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"4176_CR37","first-page":"661","volume":"12","author":"JV de Assis","year":"2022","unstructured":"de Assis JV, Coutinho LA, Oyeyemi IT, Oyeyemi OT. Diagnostic and therapeutic biomarkers in colorectal cancer: a review. Am J Cancer Res. 2022;12(2):661\u201380.","journal-title":"Am J Cancer Res"},{"key":"4176_CR38","doi-asserted-by":"crossref","unstructured":"Ebos JM, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol. 2011 Mar 1;8(4):210-21. doi: 10.1038\/nrclinonc.2011.21. Erratum in: Nat Rev Clin Oncol. 2011 Jun;8(6):316. Erratum in: Nat Rev Clin Oncol. 2011;8(4):221. PMID: 21364524; PMCID: PMC4540336.","DOI":"10.1038\/nrclinonc.2011.21"},{"issue":"29","key":"4176_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038997","volume":"103","author":"B Bolat Kucukzeybek","year":"2024","unstructured":"Bolat Kucukzeybek B, Dere Y, Akder Sari A, Ocal I, Avcu E, Dere O, et al. The prognostic significance of CD117-positive mast cells and microvessel density in colorectal cancer. Medicine. 2024;103(29):e38997.","journal-title":"Medicine"},{"issue":"11","key":"4176_CR40","volume":"15","author":"S Pandey","year":"2023","unstructured":"Pandey S, Shukla S, Vagha S. Utility of CD34 in assessing microvessel density and its correlation with clinicopathological parameters in colorectal carcinoma patients. Cureus. 2023;15(11):e49186.","journal-title":"Cureus"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04176-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:32:21Z","timestamp":1779204741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04176-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04176-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for the use of archived samples (2017\/6A\/I\/ Cancer colorectal\/V1) was obtained from the Ethics Committee of the Institut Pasteur de Tunis, which is registered with the U.S. Office for Human Research Protections under the reference IORG001040. All procedures were performed in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments. The study was conducted in full accordance with good clinical practices, with a firm commitment to maintaining the confidentiality and anonymity of all samples used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}